Drug details

Amondys 45 (casimersen injection)

type of Neurologics, Antisense Oligonucleotides

Amondys 45 (casimersen) is an antisense oligonucleotide indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients who have a confirmed mutation of the DMD gene that is amenable to exon 45 skipping.

This drug may have the following side effects:

• nausea,
• fever,
• upper respiratory tract infection,
• joint pain,
• headache,
• cough,
• lightheadedness
• ear infection,
• mouth and throat pain,
• ear pain,
• post-traumatic pain,
• dizziness, and

The following drugs are related to Amondys 45, either as a replacement or used together:

• Emflaza (deflazacort oral suspension)
• Exondys 51 (eteplirsen injection)
• Viltepso (viltolarsen injection)